Chen Q, Espey MG, Krishna MC, et al.Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102:13604-13609.
2.
Agus DB, Vera JC, Golde DW. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res. 1999;59:4555-4558.
3.
Lamson DW, Brignall MS. Antioxidants in cancer therapy: their actions and interactions with oncologic therapies. Altern Med Rev. 1999;4:304-329.
4.
Lamson DW, Brignall MS. Antioxidants and cancer therapy II: quick reference guide. Altern Med Rev. 2000;5:152-163.
5.
Lamson DW, Brignall MS. Antioxidants and cancer, part 3: quercetin. Altern Med Rev. 2000;5:196-208.
6.
Moss RW. Antioxidants Against Cancer. New York, NY: Equinox Press; 1999.
7.
Gonzalez MJ, Mora EM, Miranda-Massari JR, Matta J, Riordan HD, Riordan NH. Inhibition of human breast carcinoma cell proliferation by ascorbate and copper. P R Health Sci J. 2002;21:21-23.
8.
Casciari JJ, Riordan HD, Miranda-Massari JR, Gonzalez MJ. Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs. P R Health Sci J. 2005;24:145-150.
9.
Riordan HD, Riordan NH, Jackson JA, et al.Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. PR Health Sci J. 2004;23:115-118.
10.
Gonzalez MJ, Miranda-Massari JR, Mora EM, et al.Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005;4:32-44.
